GC Pharma Reports Full Year 2017 Results
YONGIN, South Korea, Feb. 4, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended31 December 2017. Key Figures Full Year 2017 Growth(1) Total revenues KRW 1,287...
2018-02-05 10:46
180
GC Pharma Confirms Phase 2/3 Clinical Trial of New Protein Therapy for Hepatitis B
YONGIN, South Korea, Jan. 18, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced that it will proceed with a Phase 2/3 clinical trial for GC1102 (also known as Hepabig-gene), the company's investigati...
2018-01-18 08:00
471
